Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02347670 · ClinicalTrials.gov registry record · NA
Comparison Study of Glaucoma Eye Care Follow-Up Adherence in a High Risk Population
A NA study, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 155
- Enrollment target
NCT02347670: Completed NA study, sponsored by Wills Eye.
NCT02347670 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 155 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02347670, a NA study, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 155 participants
- Enrollment target
Study Summary
The project aims to determine the effectiveness of a patient-centered health care delivery system focused on improving follow-up adherence in patients diagnosed with glaucoma. Over the course of 1 year, a 6-person team comprised of one attending physician; project managers and community health educators, ophthalmic technician, and patient navigators will complete a baseline visit, baseline assessment and 2-3 follow-up visits. The patient navigator will assist participants in community groups and a portion of the office-based participants with scheduling follow-up appointments
Primary Outcome
Using data from randomized patients only, we will fit population average Poisson regression models using generalized estimating equations to estimate the rates of timely attendance by randomization assignment and assess the efficacy of the interventions while accounting for within-site clustering. The primary analysis will be adjusted for baseline individual characteristics believed to be associated with adherence to follow-up including age, glaucoma diagnosis, geriatric depression score, and ov
Interventions
- BEHAVIORAL Efficacy-patient navigator to improve follow-up adherence
- BEHAVIORAL Office-Based Usual Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT02347670 record still lists
NCT02347670 is an interventional study that assigns participants to a tested intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Efficacy-patient navigator to improve follow-up adherence is the first listed.
NCT02347670 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02347670 about?
NCT02347670 is a clinical study titled "Comparison Study of Glaucoma Eye Care Follow-Up Adherence in a High Risk Population". The project aims to determine the effectiveness of a patient-centered health care delivery system focused on improving follow-up adherence in patients diagnosed with glaucoma. Over the course of 1 year, a 6-person team comprised of one attending physician; project managers and community health educa...
What is the current status of trial NCT02347670?
This trial is currently completed. It is a NA study. The enrollment target is 155 participants. The study started on 2014-08. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02347670?
The interventions under investigation include: Efficacy-patient navigator to improve follow-up adherence (BEHAVIORAL), Office-Based Usual Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT02347670?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02347670's enrollment target sits among peer trials
155 656th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia